Search Within

Francisco Sanchez Vega

Formats
  1. Journal Article (85)
  2. Meeting Abstract (43)
  3. Editorial (4)
  4. Review (3)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Computational Oncology Service (137)
  2. Epidemiology and Biostatistics (137)
  3. Sloan Kettering Institute Postdocs (137)
  4. Surgery (137)
  5. GSK Faculty (103)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (96)

More Groups

People
  1. Nikolaus Schultz (80)
  2. Walid Chatila (36)
  3. Julio Garcia Aguilar (29)
  4. David Solit (27)
  5. Michael Berger (27)
  6. Ritika Kundra (26)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (9)
  4. 2022 (18)
  5. 2021 (20)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Cancer Research (13)
  3. Nature Communications (13)
  4. Clinical Cancer Research (9)
  5. Cancer Cell (8)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. American Association for Cancer Research (27)
  2. Nature Publishing Group (24)
  3. American Society of Clinical Oncology (22)
  4. Cell Press (16)
  5. Oxford University Press (10)
  6. Springer (6)

More Publishers

Results (137)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity
    Meeting Abstract

    Razavi, P.; Li, Q.; Li, Z.; Brown, D. N.; Ping, C.; Shen, R.; Sanchez-Vega, F.; Schultz, N. D.; Baselga, J.; Scaltriti, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A molecular and histopathologic map of cancer metastasis
    Meeting Abstract

    Sanchez-Vega, F.; Fong, C.; Chatila, W.; Jonsson, P.; Penson, A. V.; DiNatale, R. G.; Berger, M. F.; Zehir, A.; Reznik, E.; Gao, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
    Journal Article

    Xu, J.; Reznik, E.; Lee, H. J.; Gundem, G.; Jonsson, P.; Sarungbam, J.; Bialik, A.; Sanchez-Vega, F.; Creighton, C. J.; Hoekstra, J.; more...
    eLife (2019)

    Fulltext@MSK | Save
  • Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
    Editorial

    Ladanyi, M.; Sanchez Vega, F.; Zauderer, M.
    Genome Medicine (2019)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save